Aaron Mark Drucker

Aaron Mark Drucker

Auto-generated profile, based on publicly available information

Aaron Mark Drucker

Department of Medicine and Research and Innovation Institute, Women’s College Hospital , Toronto, ON

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
ADAaron M. Drucker
Aaron M. Drucker
AWAnnie R. Wang
Annie R. Wang
WLWen-Qing Li
Wen-Qing Li
ESErika Sevetson
Erika Sevetson
JBJulie K. Block
Julie K. Block
AQAbrar A. Qureshi
Abrar A. Qureshi

1 November 2016 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
ADAaron M. Drucker
Aaron M. Drucker
PFPatrick Fleming
Patrick Fleming
ACAn-Wen Chan
An-Wen Chan

28 January 2018 in British Journal of Dermatology
Verified
Journal Article
Open access
PDF file
ADA.M. Drucker
A.M. Drucker
KEK. Eyerich
K. Eyerich
MBM.S. de Bruin-Weller
M.S. de Bruin-Weller
JTJ.P. Thyssen
J.P. Thyssen
PSP.I. Spuls
P.I. Spuls
EGE. Guttman-Yassky
E. Guttman-Yassky
Guidelines discourage the use of systemic corticosteroids for atopic dermatitis but their use remains widespread. To reach consensus among an international group of atopic dermatitis experts on the use of systemic corticosteroids for atopic dermatitis. A survey consisting of statements accompanied by visual analog scales ranging from “strongly disagree” to “neutral” to “strongly agree” was distributed to the International Eczema Council (IEC). Consensus was reached in agreement on a statement if <30% of respondents marked to the left of “neutral” towards “strongly disagree.” Sixty of 77 (79%) IEC members participated. Consensus was reached on 12 statements, including that systemic corticosteroids should generally be avoided but can be used rarely for severe atopic dermatitis under certain circumstances, including a lack of other treatment options, as a bridge to other systemic therapies or phototherapy, during acute flares in need of immediate relief, in anticipation of a major life event or in the most severe cases. If used, treatment should be limited to short-term. Most respondents agreed that systemic corticosteroids should never be used in children, but consensus was not reached on that statement. The conclusions of our expert group are limited by a dearth of high-quality published evidence. If more stringent consensus criteria were applied (e.g., requiring <20% of respondents marking towards “strongly disagree,” consensus would have been reached on fewer statements. Based on expert opinion from the IEC, routine use of systemic corticosteroids for atopic dermatitis is generally discouraged and should be reserved for special circumstances.

1 May 2021 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
CJChristine E. Jo
Christine E. Jo
AFAlexandra Finstad
Alexandra Finstad
JGJorge R. Georgakopoulos
Jorge R. Georgakopoulos
VPVincent Piguet
Vincent Piguet
JYJensen Yeung
Jensen Yeung
ADAaron M. Drucker
Aaron M. Drucker

1 October 2011 in Drug Safety
Verified
Journal Article
Closed access
PDF file
ADAaron M. Drucker
Aaron M. Drucker
CRCheryl F. Rosen
Cheryl F. Rosen

1 January 2018 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
PFPatrick Fleming
Patrick Fleming
ADAaron M. Drucker
Aaron M. Drucker